Status:
RECRUITING
Registry on Percutaneous Electrochemotherapy
Lead Sponsor:
Cardiovascular and Interventional Radiological Society of Europe
Conditions:
Primary Liver Cancer
Secondary Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Registry on Percutaneous ElectroChemoTherapy (RESPECT) is a post-market, prospective, non-randomized, observational study aiming at evaluating the effectiveness of percutaneous electrochemotherapy...
Detailed Description
Electrochemotherapy (ECT) is a local tumour ablation technique that uses reversible electroporation to transiently permeabilize the cell membrane in order to increase the cytotoxicity of chemotherapeu...
Eligibility Criteria
Inclusion
- 18 years or older
- Primary or secondary liver cancer
- Referral to local ablative treatment by multidisciplinary tumour board and decision to treat with pECT by interventional radiologist in charge
- Planned treatment with pECT using the CLINIPORATOR
- Signed informed consent form
Exclusion
- Pregnancy
Key Trial Info
Start Date :
January 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05267080
Start Date
January 25 2023
End Date
January 31 2027
Last Update
January 5 2026
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Montpellier
Montpellier, France
2
Hôpital Européen Georges-Pompidou
Paris, France
3
Institut Gustave Roussy
Paris, France
4
WEGE Klinik
Bonn, Germany